Zobrazeno 1 - 10
of 36
pro vyhledávání: '"N. S. Tchekmedyian"'
Publikováno v:
Onkourologiâ, Vol 4, Iss 1 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::19c3e29e7fecde2b2fd2ebc60bd59389
https://oncourology.abvpress.ru/oncur/article/view/1046
https://oncourology.abvpress.ru/oncur/article/view/1046
Autor:
A B Colowick, N S Tchekmedyian, G. Rossi, Glen R. Justice, S Armstrong, J. Jadeja, J Kessler, J O'Byrne, John A. Glaspy, D Richards, Lee S. Schwartzberg
Publikováno v:
British Journal of Cancer
British journal of cancer, vol 87, iss 3
British journal of cancer, vol 87, iss 3
In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g. kg−1 wk−1 or to a control group receiving epoetin alfa at an initial dose of 150 U kg−1 three times weekly. In part B, the coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a25a1cc10e213daf4707f1a43bc274dc
https://doi.org/10.1038/sj.bjc.6600465
https://doi.org/10.1038/sj.bjc.6600465
Autor:
M Rarick, U Gayko, L A Meza, I A Jaiyesimi, S Brosman, N S Tchekmedyian, A B Colowick, M Murdoch, D Chan, John A. Glaspy, Ronald M. Bukowski, A Saven, H Griffith, R E Smith, Alex Fleishman
Publikováno v:
British Journal of Cancer
Anaemia is a common haematologic disorder in patients with cancer and has a multifactorial aetiology, including the effects of the malignancy itself and residual effects from previous therapy. Novel erythropoiesis stimulating protein (NESP, darbepoet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eead186334ee2709ce5598e8758476c
http://europepmc.org/articles/PMC2363901
http://europepmc.org/articles/PMC2363901
Autor:
J. M. Ribaudo, David Cella, William T. Leslie, Stephen Lloyd, Elizabeth A. Hahn, J H Von Roenn, N S Tchekmedyian
Publikováno v:
Quality of Life Research. 9:1137-1146
Purpose: The original Functional Assessment of Anorexia/Cachexia Therapy (FAACT) was designed to measure general aspects of quality of life (QOL) as well as specific anorexia/cachexia-related concerns. Our primary purpose was to reduce the number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fa2af92399943d254a0493b97d375d0
https://doi.org/10.1023/a:1016670403148
https://doi.org/10.1023/a:1016670403148
Autor:
Thomas M. Beck, B Greenberg, N S Tchekmedyian, Rudolph M. Navari, K C Caldwell, H Garewal, Stefan Madajewicz, N Anderson, W Whaley, A Y Chang
Publikováno v:
Journal of Clinical Oncology. 13:2408-2416
PURPOSE To investigate the efficacy and safety of oral ondansetron in the control of cisplatin-induced delayed emesis in patients who do not require rescue antiemetic therapy for acute emesis. PATIENTS AND METHODS Five hundred thirty-eight chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5bd5fa98f51bed4448880e84416b65
https://doi.org/10.1200/jco.1995.13.9.2408
https://doi.org/10.1200/jco.1995.13.9.2408
Autor:
N. S. Tchekmedyian, A. R. Johri, Celestia S. Higano, A. D. Baron, A. Hussain, Robert S. DiPaola
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 20(3)
Background Drug resistance mechanisms can reduce response rate and duration in men with castration-resistant prostate cancer (CRPC) receiving docetaxel-based therapy. Patupilone (epothilone B), a microtubule-targeting agent, may be unaffected by some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfec98344b547590485687dd47b7d5c8
https://pubmed.ncbi.nlm.nih.gov/19087985
https://pubmed.ncbi.nlm.nih.gov/19087985
Autor:
D Chan, G. Rossi, R E Smith, Donald W. Northfelt, N S Tchekmedyian, R Patel, M. Austin, A B Colowick, John A. Glaspy, L A Meza
Publikováno v:
British Journal of Cancer
A multicentre study evaluated the efficacy and safety of darbepoetin alpha administered weekly (QW), every 3 weeks (Q3W), and every 4 weeks (Q4W) to anaemic patients with cancer not concurrently receiving chemotherapy or radiotherapy. The QW portion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c2e7a0381b75adcf86bc48ce6a648b
https://pubmed.ncbi.nlm.nih.gov/12799626
https://pubmed.ncbi.nlm.nih.gov/12799626
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 9(10)
The original Functional Assessment of Anorexia/Cachexia Therapy (FAACT) was designed to measure general aspects of quality of life (QOL) as well as specific anorexia/cachexia-related concerns. Our primary purpose was to reduce the number of anorexia/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b259f5c451e3e3a636d565ae0bd8061c
https://pubmed.ncbi.nlm.nih.gov/11401046
https://pubmed.ncbi.nlm.nih.gov/11401046
Autor:
N S, Tchekmedyian
Publikováno v:
Oncology (Williston Park, N.Y.). 9
Patients with advanced cancer or AIDS are frequently bothered by anorexia, decreased food intake, fatigue, weight loss, muscle wasting, and a decline in functional status. Nutritional support may afford these patients a better, although not longer li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70fbf8de405d69f2846648c4324b4e88
https://pubmed.ncbi.nlm.nih.gov/8608060
https://pubmed.ncbi.nlm.nih.gov/8608060